All In Biotech

Drug Trial Radar · NCT07553637

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

A Randomized, Double-blind, Placebo-controlled Trial of ALTO-207 in Adults With Treatment-resistant Depression

Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 178 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

178

Planned (sponsor's estimate)

Start

May 20, 2026

Primary completion

Nov 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Alto NeuroscienceIndustry
Sponsor type
Industry
First posted
Apr 28, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is to measure depressive symptoms following treatment with ALTO-207 compared with placebo in participants with TRD.

Conditions

  • Treatment-resistant Depression (TRD)

Interventions

  • ALTO-207Drug

    ALTO-207 BID

  • PlaceboDrug

    Matching Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in the MADRS total scoreTime frame: Change from baseline up to 8 weeks

Locations

63 sites in 2 countries. Site status is shown where the registry gives one.

  • Site 7173

    Dothan, Alabama · Recruiting

  • Site 7000

    Phoenix, Arizona · Recruiting

  • Site 7153

    Chino, California · Recruiting

  • Site 7195

    La Jolla, California · Not yet recruiting

  • Site 7069

    Los Angeles, California · Recruiting

  • Site 7156

    Oakland, California · Recruiting

  • Site 7082

    Oceanside, California · Recruiting

  • Site 7159

    Palo Alto, California · Not yet recruiting

  • Site 7016

    Sacramento, California · Recruiting

  • Site 7144

    San Diego, California · Recruiting

  • Site 7120

    San Jose, California · Recruiting

  • Site 7171

    Valley Village, California · Recruiting

  • Site 7200

    Wilton, Connecticut · Not yet recruiting

  • Site 7152

    Saint Augustine, Florida · Recruiting

  • Site 7148

    Albany, Georgia · Recruiting

  • Site 7146

    Marietta, Georgia · Recruiting

  • Site 7141

    Savannah, Georgia · Recruiting

  • Site 7064

    Snellville, Georgia · Recruiting

  • Site 7192

    Naperville, Illinois · Recruiting

  • Site 7169

    Indianapolis, Indiana · Recruiting

  • Site 7151

    Annapolis, Maryland · Withdrawn

  • Site 7185

    Baltimore, Maryland · Not yet recruiting

  • Site 7054

    Pikesville, Maryland · Recruiting

  • Site 7180

    Rockville, Maryland · Recruiting

  • Site 7166

    Worcester, Massachusetts · Recruiting

  • Site 7155

    Ann Arbor, Michigan · Recruiting

  • Site 7154

    Bloomfield Hills, Michigan · Recruiting

  • Site 7178

    Grand Rapids, Michigan · Not yet recruiting

  • Site 7189

    St Louis, Missouri · Recruiting

  • Site 7066

    Toms River, New Jersey · Recruiting

  • Site 7170

    Amherst, New York · Recruiting

  • Site 7055

    Cedarhurst, New York · Recruiting

  • Site 7162

    Lewiston, New York · Recruiting

  • Site 7157

    Syracuse, New York · Recruiting

  • Site 7127

    Cary, North Carolina · Recruiting

  • Site 7143

    Charlotte, North Carolina · Recruiting

  • Site 7029

    Cincinnati, Ohio · Recruiting

  • Site 7194

    Dayton, Ohio · Not yet recruiting

  • Site 7158

    Garfield Heights, Ohio · Recruiting

  • Site 7172

    East Providence, Rhode Island · Recruiting

Showing 40 of 63 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.